Skip to main content
. 2022 May 13;2022:8604216. doi: 10.1155/2022/8604216

Figure 3.

Figure 3

Validation of this signature in GEO. (a) Multivariable Cox regression of 3 genes in the signature. (b) PCA plot for prostate cancer patients. (c) PRAD patient distribution according to signature. (d) BFFS status and BFFS risk score distributions. (e) KM curves for the BFFS. (f) ROC curves of the signature.